IBI397 or Combination Therapies in Patients With Advanced Malignancies

Clinical trial NCT05245916 · WITHDRAWN

Trial details

NCT number: NCT05245916
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancies

Start date: 2022-04-14
Primary completion: 2023-08-24
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.